These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 32512122)

  • 21. The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study.
    Mangion K; Morrow A; Bagot C; Bayes H; Blyth KG; Church C; Corcoran D; Delles C; Gillespie L; Grieve D; Ho A; Kean S; Lang NN; Lennie V; Lowe DJ; Kellman P; Macfarlane PW; McConnachie A; Roditi G; Sykes R; Touyz RM; Sattar N; Wereski R; Wright S; Berry C
    Cardiovasc Res; 2020 Dec; 116(14):2185-2196. PubMed ID: 32702087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial injury and COVID-19: Possible mechanisms.
    Babapoor-Farrokhran S; Gill D; Walker J; Rasekhi RT; Bozorgnia B; Amanullah A
    Life Sci; 2020 Jul; 253():117723. PubMed ID: 32360126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective.
    Ruzzenenti G; Maloberti A; Giani V; Biolcati M; Leidi F; Monticelli M; Grasso E; Cartella I; Palazzini M; Garatti L; Ughi N; Rossetti C; Epis OM; Giannattasio C;
    High Blood Press Cardiovasc Prev; 2021 Sep; 28(5):439-445. PubMed ID: 34173942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin-converting enzyme 2 and pericytes in cardiac complications of COVID-19 infection.
    Robinson FA; Mihealsick RP; Wagener BM; Hanna P; Poston MD; Efimov IR; Shivkumar K; Hoover DB
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1059-H1068. PubMed ID: 33036546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial injury in patients with SARS-CoV-2 pneumonia: Pivotal role of inflammation in COVID-19.
    Melillo F; Napolano A; Loffi M; Regazzoni V; Boccellino A; Danzi GB; Cappelletti AM; Rovere-Querini P; Landoni G; Ingallina G; Stella S; Ancona F; Dagna L; Scarpellini P; Ripa M; Castagna A; Tresoldi M; Zangrillo A; Ciceri F; Agricola E
    Eur J Clin Invest; 2022 Jan; 52(1):e13703. PubMed ID: 34706062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers of Cardiac Stress and Cytokine Release Syndrome in COVID-19: A Review.
    Gordon JS; Drazner MH
    Curr Heart Fail Rep; 2021 Jun; 18(3):163-168. PubMed ID: 33666855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging Role of Platelet-Endothelium Interactions in the Pathogenesis of Severe SARS-CoV-2 Infection-Associated Myocardial Injury.
    Rossouw TM; Anderson R; Manga P; Feldman C
    Front Immunol; 2022; 13():776861. PubMed ID: 35185878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Covid-19 and the cardiovascular system: a comprehensive review.
    Azevedo RB; Botelho BG; Hollanda JVG; Ferreira LVL; Junqueira de Andrade LZ; Oei SSML; Mello TS; Muxfeldt ES
    J Hum Hypertens; 2021 Jan; 35(1):4-11. PubMed ID: 32719447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience.
    De Michieli L; Babuin L; Vigolo S; Berti De Marinis G; Lunardon A; Favretto F; Lobo R; Sandoval Y; Bryant SC; Donato D; Plebani M; Vettor R; Iliceto S; Cianci V; Jaffe AS
    Clin Biochem; 2021 Apr; 90():8-14. PubMed ID: 33529580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 and Acute Cardiac Injury: Clinical Manifestations, Biomarkers, Mechanisms, Diagnosis, and Treatment.
    Qiu H; Li J; Li J; Li H; Xin Y
    Curr Cardiol Rep; 2023 Aug; 25(8):817-829. PubMed ID: 37314650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 and Acute Myocardial Injury and Infarction: Related Mechanisms and Emerging Challenges.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):399-414. PubMed ID: 33949887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Sensitivity Cardiac Troponin T for the Detection of Myocardial Injury and Risk Stratification in COVID-19.
    De Michieli L; Ola O; Knott JD; Akula A; Mehta RA; Hodge DO; Dworak M; Yang EH; Gharacholou M; Singh G; Singh R; Gulati R; Jaffe AS; Sandoval Y
    Clin Chem; 2021 Aug; 67(8):1080-1089. PubMed ID: 33860295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markers of myocardial injury in the prediction of short-term COVID-19 prognosis.
    Calvo-Fernández A; Izquierdo A; Subirana I; Farré N; Vila J; Durán X; García-Guimaraes M; Valdivielso S; Cabero P; Soler C; García-Ribas C; Rodríguez C; Llagostera M; Mojón D; Vicente M; Solé-González E; Sánchez-Carpintero A; Tevar C; Marrugat J; Vaquerizo B
    Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):576-583. PubMed ID: 33153955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study.
    Gorecka M; McCann GP; Berry C; Ferreira VM; Moon JC; Miller CA; Chiribiri A; Prasad S; Dweck MR; Bucciarelli-Ducci C; Dawson D; Fontana M; Macfarlane PW; McConnachie A; Neubauer S; Greenwood JP;
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):77. PubMed ID: 34112195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.
    Bojkova D; Wagner JUG; Shumliakivska M; Aslan GS; Saleem U; Hansen A; Luxán G; Günther S; Pham MD; Krishnan J; Harter PN; Ermel UH; Frangakis AS; Milting H; Zeiher AM; Klingel K; Cinatl J; Dendorfer A; Eschenhagen T; Tschöpe C; Ciesek S; Dimmeler S
    Cardiovasc Res; 2020 Dec; 116(14):2207-2215. PubMed ID: 32966582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression.
    Amendola A; Garoffolo G; Songia P; Nardacci R; Ferrari S; Bernava G; Canzano P; Myasoedova V; Colavita F; Castilletti C; Sberna G; Capobianchi MR; Piacentini M; Agrifoglio M; Colombo GI; Poggio P; Pesce M
    Cardiovasc Res; 2021 May; 117(6):1557-1566. PubMed ID: 33705542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac manifestations of COVID-19 in Shenzhen, China.
    Zeng JH; Wu WB; Qu JX; Wang Y; Dong CF; Luo YF; Zhou D; Feng WX; Feng C
    Infection; 2020 Dec; 48(6):861-870. PubMed ID: 32725595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac biomarkers alterations in patients with SARS-CoV-2 infection.
    Oikonomou E; Paraskevas T; Velissaris D
    Rom J Intern Med; 2022 Mar; 60(1):6-13. PubMed ID: 34610232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use and Prognostic Implications of Cardiac Troponin in COVID-19.
    De Michieli L; Jaffe AS; Sandoval Y
    Cardiol Clin; 2022 Aug; 40(3):287-300. PubMed ID: 35851452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
    Imazio M; Klingel K; Kindermann I; Brucato A; De Rosa FG; Adler Y; De Ferrari GM
    Heart; 2020 Aug; 106(15):1127-1131. PubMed ID: 32499236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.